Bone marrow fibrosis in patients with primary myelodysplastic syndromes has prognostic value using current therapies and new risk stratification systems
Modern Pathology2013Vol. 27(5), pp. 681–689
Citations Over TimeTop 14% of 2013 papers
Bin Fu, Jesse Jaso, Rachel L. Sargent, Maitrayee Goswami, Srđan Verstovšek, L. Jeffrey Medeiros, Sa A. Wang
Related Papers
- → Assessing the Prognosis of Patients with Myelodysplastic Syndromes (MDS)(2022)16 cited
- → High flow cytometric scores identify adverse prognostic subgroups within the revised international prognostic scoring system for myelodysplastic syndromes(2014)34 cited
- → P-113 Revised International Prognostic Scoring System (IPSS-R) for primary treated myelodysplastic syndromes (MDS) patients: A report from the IWG-PM(2013)4 cited
- → [Molecular international prognostic scoring system for myelodysplastic syndromes].(2023)1 cited
- → 237 CLINICIAN UTILIZATION OF THE INTERNATIONAL PROGNOSTIC SCORING SYSTEM (IPSS) FOR NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROMES (MDS) PATIENTS(2015)